Promising treatment options of triple negative breast cancer

Abstract

Triple negative breast cancer constitutes a histologically, molecularly and immunologically heterogeneous group of diseases,characterized by lack of α-estrogen, progesteron receptors and HER2 expression. This review presents recent studies of promisingtreatment options of triple negative breast cancer.

Keywords

• triple negative breast carcinoma
• platinum derivates
• olaparib
• bevacizumab
• eribulin
• pembrolizumab